TY  - GEN
AU  - Beer,Ambros J
AU  - Schwaiger,Markus
TI  - PET of αvbeta3-integrin and αvbeta5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: ready for prime time?
SN  - 1535-5667
PY  - 2011///0412
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Animals
KW  - Cell Line, Tumor
KW  - Glioblastoma
KW  - diagnostic imaging
KW  - Humans
KW  - Indoles
KW  - Integrin alphaVbeta3
KW  - metabolism
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - Peptides
KW  - pharmacokinetics
KW  - Polyethylene Glycols
KW  - Pyrroles
KW  - Radionuclide Imaging
KW  - Radiopharmaceuticals
KW  - Receptors, Vitronectin
KW  - Reproducibility of Results
KW  - Sensitivity and Specificity
KW  - Sunitinib
N1  - Publication Type: Journal Article; Comment
UR  - https://doi.org/10.2967/jnumed.110.078568
ER  -